Hims & Hers adding access to generic liraglutide, branded tirzepatide

In a statement posted to the newsroom of Hims & Hers (HIMS), Craig Primack stated in part: “In my experience of treating thousands of people, lasting results come from focusing on the individual, not just the condition. This simple belief has shaped the way we’ve built the Hims & Hers platform and is especially important in how we designed our weight loss offering, because we know that the condition and the treatment is never one-size-fits-all. We’re committed to bringing our customers more treatment options that best suit their needs, and we’ve now expanded that choice even further by adding access to generic liraglutide and branded tirzepatide through our platform. Weight loss is about more than medication, or even the number on the scale. It’s about helping people become a healthier, more empowered version of themselves. That means a solution must focus on treating the whole person, not just prescribing a medication and hoping for the best.” Tirzepatide is marketed by Eli Lilly (LLY) with the brand names Mounjaro and Zepbound.